Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous immunoglobulin idiotype-KLH conjugate vaccine

A cancer vaccine composed of tumor-specific idiotype determinants derived from an individual's tumor cells which are conjugated to keyhole limpet hemocyanin, an immunostimulant carrier protein. When injected into the individual from whom the tumor cells were isolated, this vaccine may stimulate an antitumoral cytotoxic T-lymphocytic immune response.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	autologous immunoglobulin idiotype-keyhole limpet hemocyanin conjugate vaccine GTOP-99 Id-KLH conjugate vaccine recombinant Id-KLH
Abbreviation:	Id-KLH

autologous immunoglobulin idiotype-KLH conjugate vaccine

Search NCI's Drug Dictionary